Abstract

Tissue homeostasis relies on the fine regulation between stem and progenitor cell maintenance and lineage commitment. In the adult prostate, stem cells have been identified in both basal and luminal cell compartments. However, basal stem/progenitor cell homeostasis is still poorly understood. We show that basal stem/progenitor cell maintenance is regulated by a balance between BMP5 self-renewal signal and GATA3 dampening activity. Deleting Gata3 enhances adult prostate stem/progenitor cells self-renewal capacity in both organoid and allograft assays. This phenotype results from a local increase in BMP5 activity in basal cells as shown by the impaired self-renewal capacity of Bmp5-deficient stem/progenitor cells. Strikingly, Bmp5 gene inactivation or BMP signaling inhibition with a small molecule inhibitor are also sufficient to delay prostate and skin cancer initiation of Pten-deficient mice. Together, these results establish BMP5 as a key regulator of basal prostate stem cell homeostasis and identifies a potential therapeutic approach against Pten-deficient cancers.

Data availability

Data from this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1ABC-2C-3ABC-4AEFJ-2S1AC-4S1AB.Sequencing data have been deposited in GEO under accession codes GSE155289.

The following data sets were generated

Article and author information

Author details

  1. Mathieu Tremblay

    Biochemistry, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  2. Sophie Viala

    Biochemistry, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  3. Maxwell ER Shafer

    Biochemistry, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  4. Adda-Lee Graham-Paquin

    Biochemistry, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  5. Chloe Liu

    Biochemistry, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Maxime Bouchard

    Goodman Cancer Research Centre/ Biochemistry, McGill University, Montreal, Canada
    For correspondence
    maxime.bouchard@mcgill.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7619-9680

Funding

Canadian Institutes of Health Research (MOP-130460)

  • Maxime Bouchard

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were approved by McGill University Animal Care Committee (Permit#2011-5954) according to the Canadian Council on Animal Care guidelines for use of laboratory animals in biological research.

Copyright

© 2020, Tremblay et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,600
    views
  • 239
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mathieu Tremblay
  2. Sophie Viala
  3. Maxwell ER Shafer
  4. Adda-Lee Graham-Paquin
  5. Chloe Liu
  6. Maxime Bouchard
(2020)
Regulation of stem/progenitor cell maintenance by BMP5 in prostate homeostasis and cancer initiation
eLife 9:e54542.
https://doi.org/10.7554/eLife.54542

Share this article

https://doi.org/10.7554/eLife.54542

Further reading

    1. Stem Cells and Regenerative Medicine
    Tino Stauber, Greta Moschini ... Jess G Snedeker
    Research Article

    Tendinopathies are debilitating diseases currently increasing in prevalence and associated costs. There is a need to deepen our understanding of the underlying cell signaling pathways to unlock effective treatments. In this work, we screen cell signaling pathways in human tendinopathies and find positively enriched IL-6/JAK/STAT signaling alongside signatures of cell populations typically activated by IL-6 in other tissues. In human tendinopathic tendons, we also confirm the strong presence and co-localization of IL-6, IL-6R, and CD90, an established marker of reparative fibroblasts. To dissect the underlying causalities, we combine IL-6 knock-out mice with an explant-based assembloid model of tendon damage to successfully connect IL-6 signaling to reparative fibroblast activation and recruitment. Vice versa, we show that these reparative fibroblasts promote the development of tendinopathy hallmarks in the damaged explant upon IL-6 activation. We conclude that IL-6 activates tendon fibroblast populations which then initiate and deteriorate tendinopathy hallmarks.

    1. Stem Cells and Regenerative Medicine
    Ryosuke Isotani, Masaki Igarashi ... Toshimasa Yamauchi
    Research Article

    Cigarette smoking is a well-known risk factor inducing the development and progression of various diseases. Nicotine (NIC) is the major constituent of cigarette smoke. However, knowledge of the mechanism underlying the NIC-regulated stem cell functions is limited. In this study, we demonstrate that NIC increases the abundance and proliferative activity of murine intestinal stem cells (ISCs) in vivo and ex vivo. Moreover, NIC induces Yes-associated protein (YAP) /Transcriptional coactivator with PDZ-binding motif (TAZ) and Notch signaling in ISCs via α7-nicotinic acetylcholine receptor (nAchR) and protein kinase C (PKC) activation; this effect was not detected in Paneth cells. The inhibition of Notch signaling by dibenzazepine (DBZ) nullified the effects of NIC on ISCs. NIC enhances in vivo tumor formation from ISCs after loss of the tumor suppressor gene Apc, DBZ inhibited NIC-induced tumor growth. Hence, this study identifies a NIC-triggered pathway regulating the stemness and tumorigenicity of ISCs and suggests the use of DBZ as a potential therapeutic strategy for treating intestinal tumors.